ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,463.54
0.08%
US Tech 100
18,493.20
-0.14%
Dow Jones
40,539.93
-0.12%
Brent Oil
78.695
-0.57%
Bitcoin
66,428.02
-0.59%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX

  6. Orchid Def X Opt (ORCN) Quote

Orchid Def X Opt

Orchid Def X Opt (ORCN)

ASX
0.00
0.00
( 0.00% )
Updated: -
Delayed by 20 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

ORCN Latest News

More News

Alterity Therapeutics to Present at MST Financial Webinar

MELBOURNE, Australia and SAN FRANCISCO, July 24, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...

July 24 2024
GlobeNewswire Inc.

Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy

– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had Stable or Improved Neurological Symptoms – – Objective Biomarkers Demonstrated...

July 17 2024
GlobeNewswire Inc.

Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy

– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had Stable or Improved Neurological Symptoms – – Objective Biomarkers Demonstrated...

July 17 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

June 13 2024
Edgar (US Regulatory)

Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar

MELBOURNE, Australia and SAN FRANCISCO, June 12, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...

June 12 2024
GlobeNewswire Inc.

Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study

- New bioMUSE Data Informs ATH434-202 Study Endpoints - - Webcast to Include Key Opinion Leader, Daniel Claassen, M.D., M.S., Vanderbilt University - MELBOURNE, Australia and SAN FRANCISCO, May...

May 29 2024
GlobeNewswire Inc.

Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review

 - ATH434-201 Trial on Track to Complete in November 2024 – - Top-Line Data Expected in January 2025 - MELBOURNE, Australia and SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Alterity...

May 08 2024
GlobeNewswire Inc.

Appendix 4C – Q3 FY24 Quarterly Cash Flow Report

Highlights ATH434-201 Phase 2 baseline data confirm approach to target biomarkers for slowing disease progressionPresented promising nonclinical data on ATH434 in a primate model of Parkinson’s...

April 30 2024
GlobeNewswire Inc.

Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia

–   New Evidence Indicates ATH434 can Function as an Iron Chaperone to Redistribute Iron   – MELBOURNE, Australia and SAN FRANCISCO, April 29, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics...

April 29 2024
GlobeNewswire Inc.

Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting

– ATH434 Improved Motor Performance and General Function in a Primate Model of Parkinson’s Disease – – ATH434-201 Phase 2 Baseline Data Confirm Approach to Target Biomarkers for Slowing Disease...

April 17 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CNQOClean TeQ Water Ltd
AUD 0.01
(100.00%)
116.67k
AHNOAthena Resources Ltd
AUD 0.002
(100.00%)
2.75M
APCAustralian Potash Limited
AUD 0.0015
(50.00%)
517.86k
A1GAfrican Gold Limited
AUD 0.034
(41.67%)
11.94M
AAUAntilles Gold Limited
AUD 0.004
(33.33%)
800k
ICLOIceni Gold Limited
AUD 0.01
(-50.00%)
500k
HAROHaranga Resources Ltd
AUD 0.003
(-40.00%)
5k
RCRRincon Resources Limited
AUD 0.052
(-32.47%)
26.93M
LM1Leeuwin Metals Ltd
AUD 0.06
(-28.57%)
37.12k
ADOOAnteoTech Limited
AUD 0.006
(-25.00%)
3.82M
TEGTriangle Energy Global Limited
AUD 0.015
(-11.76%)
41.51M
RCRRincon Resources Limited
AUD 0.052
(-32.47%)
26.93M
HLXHelix Resources Limited
AUD 0.003
(20.00%)
22.88M
TRITrivarX Ltd
AUD 0.039
(5.41%)
15.59M
FMGFortescue Ltd
AUD 18.57
(-8.70%)
12.41M

Discussion

View Full Feed
blackhawks blackhawks 2 minutes ago
Don't f'cking patronize me with that 'don't be a sucker' bull💩.

'Involuntary' is not mutually exclusive with 'unable'. In this instance it's synonymous.
thegreencandle thegreencandle 2 minutes ago
Lmao... Wonder where the intern is.

Kinda funny what happens after they go dark and stop communication with shareholders. Someone remind me how much company leadership appreciates and cares about their shareholders lol

At least they can't scam anyone else anymore. Good
PCTL
arizona1 arizona1 3 minutes ago
There is no such thing as an involuntary celibate.

MAGA men can't get a date. That's why they become "youth pastors" and molest children. #incel

Full List of Texas Pastors Charged With Abusing Children This Year
https://www.newsweek.com/full-list-texas-pasto
nowwhat2 nowwhat2 3 minutes ago
Never even entered their MINDS that one could see a pullback here......LoL

https://investorshub.advfn.com/uimage/uploads/2024/7/29/idrbgETH_777_29_1Y_630pm_TL_plain_dot_ON.jpg

https://investorshub.advfn.com/uimage/uploads/2024/7/29/sfbytbtc_777_29_1y_630pm_w_ETH_LINES_T
BTCUSD
Monroe1 Monroe1 3 minutes ago
https://ih.advfn.com/stock-market/USOTC/north-bay-resources-pk-NBRI/stock-news/94215665/north-bay-resources-acquires-mt-vernon-gold-mine

Once the mill is fully operational the next step will be to expand it's capacity to handle the demand locally.

I would entertain tal
NBRI
mick mick 3 minutes ago
https://www.pgatour.com/article/news/expert-picks/2024/02/20/fantasy-golf-advice-tips-picks-mexico-open-at-vidanta-vallarta-tony-finau
mick mick 3 minutes ago
https://www.pgatour.com/article/news/expert-picks/2024/02/20/fantasy-golf-advice-tips-picks-mexico-open-at-vidanta-vallarta-tony-finau
Nsnz33 Nsnz33 4 minutes ago
Janel Felon is an agent of the Rothschilds, we are all unwittingly slaves to the Rothschilds and their central banking cartel comprised of the "federal" reserve, bank of england, bank of japan, european central bank, BIS, and beyond.

The proposition that Janet Felon "is crazy and out
FFMGF
threewheeler threewheeler 4 minutes ago
GMSacha Inchi $QEDN
@GMSachaInchi
·
2h
GMSacha Inchi, $QEDN many shareholder's have asked for a second chance to particiapte on the Google Meet July 31, 2024 at 6:00 pm EST to hear the upcoming news of $QEDN. Updates on Nestle, Grupo Nutresa, Vitacost-Kroger and more.
QEDN
neomania neomania 4 minutes ago
NSAV stopped talking about Divinci Pay NSAV Pay.
NSAV
mick mick 4 minutes ago
https://www.pgatour.com/article/news/power-rankings/2024/02/19/fantasy-golf-advice-tips-picks-mexico-open-at-vidanta-vallarta-tony-finau?deviceId=e5b56fac-772f-46bc-8281-240ca5b220df
mick mick 4 minutes ago
https://www.pgatour.com/article/news/power-rankings/2024/02/19/fantasy-golf-advice-tips-picks-mexico-open-at-vidanta-vallarta-tony-finau?deviceId=e5b56fac-772f-46bc-8281-240ca5b220df
Lime Time Lime Time 6 minutes ago
Okay, so the board was censored. That's OK. I really didn't understand your last sentence, though.

Than you.
treasurevalley treasurevalley 6 minutes ago
Don't forget this went from 0.009 to 0.0054 around 60 days ago for all the new ones. Somebody did make money.
DPLS
joe botts joe botts 6 minutes ago
Great time of the year
.
Golden Cross Golden Cross 9 minutes ago
$LDSN LUDUSON G INC. Announces Plans to Enhance Metaverse Experience in Latest Development Project
https://finance.yahoo.com/news/luduson-g-inc-otc-ldsn-140000815.html
LDSN
INFINITI INFINITI 9 minutes ago
$$$$$$$$$$$$$$$
TIVC
Golden Cross Golden Cross 9 minutes ago
$LDSN LUDUSON G INC. Announces Plans to Enhance Metaverse Experience in Latest Development Project
https://finance.yahoo.com/news/luduson-g-inc-otc-ldsn-140000815.html
LDSN
NHPIPIXiPY$26 NHPIPIXiPY$26 10 minutes ago
Wait till the algos are AI-infused! That will be a fun stock market!

All IMO
AMC
2020trader 2020trader 10 minutes ago
nobody thinks you are credible
CLNV
mrwrn2010 mrwrn2010 10 minutes ago
Wonder if it launches before next call.
ELTP
steph1971 steph1971 10 minutes ago
What about our shares Bego2.. have any insight
WPFH
SouthCountyMicroCap SouthCountyMicroCap 10 minutes ago
TokenPro Wealth Show

Another good video by Tia Castle.


https://www.youtube.com/watch?v=-_ZQqGrR5xk
IONI
2020trader 2020trader 11 minutes ago
pumpers here can't stand reality - clnv is going nowhere except further in debt - imo
CLNV

Your Recent History

ASX
ORCN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved